JBT Corporation — Form 10-Q summary
Business context and period: John Bean Technologies Corporation (JBT; NYSE: JBT) filed this quarterly report for the three and nine months ended September 30, 2020. JBT supplies equipment, systems and services to food and beverage customers through FoodTech and to aviation customers through AeroTech. Results reflect the COVID-19 disruption. The filing identifies the registrant as John Bean Technologies Corporation, not JBT Marel Corp.
Key financial results
| Metric | Q3 2020 | Q3 2019 | Nine months 2020 | Nine months 2019 |
|---|---|---|---|---|
| Revenue | $419.2M | $489.4M | $1,288.4M | $1,400.2M |
| Operating income | $28.3M | $48.6M | $119.6M | $125.6M |
| Operating margin | 6.8% | 9.9% | 9.3% | 9.0% |
| Net income | $17.2M | $33.5M | $78.7M | $86.9M |
| Diluted EPS | $0.54 | $1.04 | $2.45 | $2.71 |
| Adjusted diluted EPS (non-GAAP) | $0.83 | $1.28 | $2.92 | $3.47 |
- Q3 revenue fell 14.3% year over year; nine-month revenue fell 8.0%. Management attributed the decline mainly to customer capital-spending delays and lower backlog, partly offset over nine months by acquisitions.
- Q3 gross margin was 30.3%, up 10 basis points, while operating margin fell 310 basis points. For the nine-month period, gross margin improved 40 basis points to 31.1% and operating margin rose 30 basis points to 9.3%.
- Q3 segment revenue was $301.0M for FoodTech, down 10.0%, and $118.2M for AeroTech, down 23.7%. Segment operating margins were 12.6% and 9.6%, respectively. FoodTech recurring revenue mix supported margins; AeroTech was pressured by lower demand, aftermarket mix, fixed-cost absorption and restructuring-related inventory impairment.
- Nine-month operating cash flow was $161.1M versus $35.1M; free cash flow, a company-defined non-GAAP measure, was $140.2M versus $14.4M. Management cited stronger collections, lower inventory investment and lower pension contributions; free cash flow included $6.5M of deferred payroll tax benefits under the CARES Act.
- At September 30, cash was $50.6M and current assets were $634.5M versus current liabilities of $434.6M. Long-term debt was $598.0M, with $0.2M of current debt. The company reported $599.8M drawn and $392.1M available under its revolving facility, and total cash plus borrowing capacity of $448M. It was in compliance with credit covenants.
Material changes and unusual items
- Q3 inbound orders totaled $421.2M versus $463.7M a year earlier: FoodTech orders rose to $310.4M from $283.3M, while AeroTech orders declined to $110.8M from $180.3M. Nine-month orders were $1,235.9M versus $1,392.6M.
- September 24 CEO Tom Giacomini resigned. Brian Deck became interim CEO and Matt Meister interim CFO; the company recorded a $6.4M separation payment, partly offset in reported SG&A by a $2.9M reversal related to forfeited stock awards. The non-GAAP reconciliation reports $3.5M of net management-succession costs.
- Q3 restructuring expense was $7.1M, plus $1.9M of restructuring-related inventory write-offs in cost of products. A new manufacturing-capacity plan is expected to cost $13M-$15M across the two segments, with remaining costs expected through 2021. The company estimated incremental savings of $7.0M through 2022.
- Debt repayments reduced borrowings under the credit facility by $108.9M during the first nine months. The company made no share repurchases in Q3 and stated it was foregoing repurchases and material acquisitions while prioritizing liquidity.
Outlook, commentary and risks
- JBT gave no specific full-year revenue or earnings guidance in the provided filing text. Management expected positive cash flow for 2020, about $10M of CARES Act deferred payroll tax benefits for the full year, and capital expenditures of $25M-$30M.
- Management said FoodTech inbound orders improved in Q3 and were higher year over year, with demand supported by food retail, quick-service restaurant drive-through and labor-saving automation needs. It expected pandemic-related uncertainty and adverse effects on customer capital spending to continue through the remainder of 2020.
- AeroTech remained affected by severely reduced passenger air travel, mobile-equipment demand and aftermarket utilization. Management expected these impacts to persist for the rest of 2020, while airport infrastructure demand and orders were expected to continue.
- COVID-19 risks include customer demand and payment capacity, supply and logistics interruptions, access to customer sites, facility staffing or closures, order delays or cancellations, and possible pressure on liquidity, debt-covenant compliance and asset valuations. Management said it could not reliably estimate the pandemic’s duration or severity.
- Management expected to assess goodwill in Q4 2020. It anticipated lower reporting-unit fair values from delayed demand but said it did not consider conditions at the filing date to be an impairment trigger. Legal matters were not expected to have a material adverse effect overall, though an unfavorable resolution could affect a particular future period. Guarantees included $144.9M of performance-related instruments; net exposure on customer financing guarantees was $0.1M.
- Management reported disclosure controls effective as of September 30, 2020. ERP implementation is ongoing and will require control testing; no material adverse impact was expected.
Important facts for investors to verify
- Whether FoodTech order momentum and recurring revenue can offset continuing weakness in equipment demand, especially in AeroTech.
- Whether management’s cash-flow and capital-spending expectations hold, considering the $6.5M CARES Act benefit already included in nine-month free cash flow and the $7.6M U.S. pension contribution made after quarter-end.
- Debt-facility availability, covenant headroom and refinancing or interest-rate exposure as pandemic conditions evolve; approximately half of drawn debt remained floating-rate at quarter-end.
- Actual restructuring costs, timing and savings, and the Q4 goodwill impairment assessment and assumptions.
- Execution of the permanent CEO search and transition, including any additional succession costs or disruption to strategy and operations.
- Non-GAAP adjusted earnings and free cash flow reconciliations, and the impact of exclusions and one-time items on comparisons with GAAP results.